✦ LIBER ✦

HCV E2 genomic variability in HCV-HIV-coinfected patients under interferon therapy

✍ Scribed by D. Neau; E. Legrand; P. Trimoulet; A.C. Jouvencel; M. Dupon; J.M. Ragnaud; M.E. Lafon

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HCV E2 genomic variability in HCV-HIV-co

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB

IL-2 induced immunocompetence in HIV/HCV

✍ A. Barreiros; J. Schlaak; C. Schramm; E. Bayer; P. Galle; H. Jaeger; H. Loehr 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 264 KB

Severe transaminitis after interferon–ri

✍ F. Bani-Sadr; E. Krastinova; D. Fromentin; L. Piroth; E. Rosenthal; Y. Quertainm 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB

Efficacy and safety of interferon and ri

✍ H. Zylberberg; Y. Benhamou; M.L. Chaix; H. Fontaine; C. Rouzioux; C. Katlama; T. 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 121 KB

Hepatitis C virus (HCV) protease variabi

✍ P Trimoulet; C Belzunce; M Faure; L Wittkop; S Reigadas; M Dupon; J-M Ragnaud; H 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

Interferon-α-2b + ribavirin promising in

📂 Article 📅 2001 🏛 Adis International Limited (now part of Wolters Kl ⚖ 120 KB